Miller VA - Search Results

1

Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer.

Miller VA, Rigas JR, Tong WP, Reid JR, Pisters KM, Grant SC, Heelan RT, Kris MG. Miller VA, et al. Cancer Chemother Pharmacol. 1997;40(5):415-8. doi: 10.1007/s002800050679. Cancer Chemother Pharmacol. 1997. PMID: 9272118 Clinical Trial.

2

Trastuzumab in the treatment of non-small cell lung cancer.

Azzoli CG, Krug LM, Miller VA, Kris MG, Mass R. Azzoli CG, et al. Among authors: miller va. Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.

3

The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.

Laurie SA, Kris MG, Portlock CS, Rosenzweig KE, Miller VA, Krug LM, Rusch VW. Laurie SA, et al. Among authors: miller va. Cancer. 2002 Jul 1;95(1):119-26. doi: 10.1002/cncr.10628. Cancer. 2002. PMID: 12115325 Free article.

4

A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis.

Downey RJ, Ng KK, Kris MG, Bains MS, Miller VA, Heelan R, Bilsky M, Ginsberg R, Rusch VW. Downey RJ, et al. Among authors: miller va. Lung Cancer. 2002 Nov;38(2):193-7. doi: 10.1016/s0169-5002(02)00183-6. Lung Cancer. 2002. PMID: 12399132 Clinical Trial.

5

A phase I trial of perillyl alcohol in patients with advanced solid tumors.

Azzoli CG, Miller VA, Ng KK, Krug LM, Spriggs DR, Tong WP, Riedel ER, Kris MG. Azzoli CG, et al. Among authors: miller va. Cancer Chemother Pharmacol. 2003 Jun;51(6):493-8. doi: 10.1007/s00280-003-0599-7. Epub 2003 Apr 15. Cancer Chemother Pharmacol. 2003. PMID: 12695855 Clinical Trial.

6

Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.

Miller VA, Johnson DH, Krug LM, Pizzo B, Tyson L, Perez W, Krozely P, Sandler A, Carbone D, Heelan RT, Kris MG, Smith R, Ochs J. Miller VA, et al. J Clin Oncol. 2003 Jun 1;21(11):2094-100. doi: 10.1200/JCO.2003.12.008. J Clin Oncol. 2003. PMID: 12775734 Clinical Trial.

7

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Krug LM, Azzoli CG, Kris MG, Miller VA, Khokhar NZ, Tong W, Ginsberg MS, Venkatraman E, Tyson L, Pizzo B, Baez V, Ng KK, Sirotnak FM. Krug LM, et al. Among authors: miller va. Clin Cancer Res. 2003 Jun;9(6):2072-8. Clin Cancer Res. 2003. PMID: 12796370 Clinical Trial.

8

'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC).

Pao W, Miller VA, Kris MG. Pao W, et al. Among authors: miller va. Semin Cancer Biol. 2004 Feb;14(1):33-40. doi: 10.1016/j.semcancer.2003.11.005. Semin Cancer Biol. 2004. PMID: 14757534 Review.

9

Phase I study of green tea extract in patients with advanced lung cancer.

Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Laurie SA, et al. Among authors: miller va. Cancer Chemother Pharmacol. 2005 Jan;55(1):33-8. doi: 10.1007/s00280-004-0859-1. Epub 2004 Aug 7. Cancer Chemother Pharmacol. 2005. PMID: 15309507 Clinical Trial.

10

Practical management of patients with non-small-cell lung cancer treated with gefitinib.

Shah NT, Kris MG, Pao W, Tyson LB, Pizzo BM, Heinemann MH, Ben-Porat L, Sachs DL, Heelan RT, Miller VA. Shah NT, et al. Among authors: miller va. J Clin Oncol. 2005 Jan 1;23(1):165-74. doi: 10.1200/JCO.2005.04.057. Epub 2004 Nov 22. J Clin Oncol. 2005. PMID: 15557594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

483 results

Search Page